Odds ratios for ever hypomagnesemia in patients on PPI compared to those who are not, separated according to CKD stage.

<p>Odds ratios for ever hypomagnesemia in patients on PPI compared to those who are not, separated according to CKD stage.</p

Survival curve for “mean PPIH” versus patients without hypomagnesaemia.

<p>Survival curve for “mean PPIH” versus patients without hypomagnesaemia.</p

Average serum magnesium increases in patients as CKD progresses in patients NOT on a proton pump inhibitor.

<p>This rise in not observed in patients on PPI (error bars demonstrate the standard deviation).</p

Odds ratios for mean and ever hypomagnesaemia, demonstrating univariate results for PPI versus not on PPI, and the results of a multivariate model.

<p>Odds ratios for mean and ever hypomagnesaemia, demonstrating univariate results for PPI versus not on PPI, and the results of a multivariate model.</p

Survival curve for “ever PPIH” versus patients without hypomagnesaemia.

<p>Survival curve for “ever PPIH” versus patients without hypomagnesaemia.</p

Summary of recruitment flow.

<p>Summary of recruitment flow.</p

Baseline demographics of control and revascularized subjects.

<p>Baseline demographics of control and revascularized subjects.</p

Survival curves for revascularized patients divided into improvers versus non-improvers, and comparing with non ARVD control patients, adjusted for baseline age, co-morbidities, and GFR.

<p>Survival curves for revascularized patients divided into improvers versus non-improvers, and comparing with non ARVD control patients, adjusted for baseline age, co-morbidities, and GFR.</p

Comparison of imaging measurements between groups divided by renal functional outcome, comparing these outcome groups for stented ARVD kidneys and non-ARVD contralateral kidneys.

<p>Between group statistical analysis is by ANCOVA.</p

Comparison of predicted versus actual outcomes for individual stented kidneys.

<p>Comparison of predicted versus actual outcomes for individual stented kidneys.</p